Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - Dr Reddys Labs
Dr Reddys Labs
BSE: 500124NSE: DRREDDYISIN: INE089A01023

25th-Jan-2013 11:50Source: BSE

Dr Reddys Labs - Dr. Reddy's announces the Launch of Desloratadine ODT (Orally Disintegrating Tablets)

Dr Reddys Laboratories has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex Reditabs in the US markets on January 24, 2013.

Board Meeting (Dr Reddys Labs)

Meeting Date

Remark

2017-05-12

Audited Results & Dividend

Sections
Follow us on
Available On